Abstract
We study the optimal design of a public funding scheme in a mixed oligopoly setting (with applications to health care and education) with one welfare-maximising public provider and two profit-maximising private providers, where all providers compete on quality and where providers included in the public funding scheme are subject to price regulation. We find that the first-best solution cannot be implemented without including (at least) one of the private providers in the public funding scheme. However, inclusion of only one of the private providers is sufficient to induce the first-best outcome. Such inclusion allows for the elimination of a negative competition externality between the private providers that, all else equal, yields underprovision of quality.
Similar content being viewed by others
Notes
See for example Siciliani et al. (2017) for an overview of the scope for competition between health care providers in five different European countries.
One specific example is Chile, where the educational system is based on three types of schools; municipal, subsidised private and entirely private schools. The first two types are mainly funded by government subsidies per student and may also receive small contributions as school charges. However, the entirely private schools do not receive any public funding and raise their revenues from charging student fees (Chumacero et al. 2011). According to the PISA 2018 results, 34% of students were enrolled in municipal schools, 56.2% in government-funded private schools, and 9.8% in independent private schools (OECD 2020).
The studies of quality compeition in mixed oliogopolies can also be seen as being part of a more general literature on quality provision by (private) profit-maximising firms, where a key question is whether an unregulated market is able to provide a socially optimal quality level (e.g., Spence 1975; Ma and Burgess 1993; Cellini et al. 2018; Willner and Grönblom 2021).
On the other hand, Ghandour (2021) studies quality competition in a mixed duopoly where the public provider is subject to price regulation while the private provider is not.
A similar study using instead a vertical differentiation framework is Stenbacka and Tombak (2018).
Given the significant presence of non-profit private providers in many health care and education markets, our assumption that private providers maximise profits is not trivial. However, non-profit status does not necessarily imply that the provider is not interested in profits, it just implies a restriction on profit distribution. In fact, a common assumption in the literature on non-profit firms is that non-profit status works like a tax on profits for otherwise profit-maximising firms, because profits must be distributed in kind instead of in cash (e.g., Glaeser and Shleifer 2001; Ghatak and Mueller 2011). This assumption is validated by empirical evidence showing that for-profit and non-profit providers often tend to respond similarly to financial incentives (see, e.g., Duggan 2002).
A profit-maximising private provider that is subject to price regulation might have incentives to ‘game’ the regulator in various ways. For example, in health care markets where funding is based on DRG pricing, a provider might miscode patients in order to obtain a higher price. By the assumptions of single-good providers and a uniform regulated price, the possibility of such gaming behaviour is disregarded in our analysis.
Notice the slight abuse of notation, since \(i=1\) implies that \(i-1=3\), and \(i=3\) implies that \(i+1=1\).
The assumption that the marginal cost of quality provision is independent of output, which is widely used in the theoretical literature on quality competition between health care providers (e.g., Lyon 1999; Barros and Martinez-Giralt 2002; Gravelle and Sivey 2010), implies that quality is a public good for the consumers of a particular provider. For an analysis of quality competition with output-dependent quality costs, see, e.g., Bardey et al. (2012).
Notice once more that, if \(i=1\), then \(i-1=3\), and if \(i=3\), then \(i+1=1\).
Notice that subscripts \(i+1\) and \(i-1\) refer to the two neighours of Provider i located in the clockwise and anticlockwise direction, respectively.
See "Appendix A" for further details.
Second-order and stability conditions are reported in "Appendix A".
With one included private provider, the quality provision of the public provider has an indirect effect on average quality and aggregate transportation costs only through the pricing decision of the private provider that remains outside the funding scheme.
Second-order and stability conditions are reported in "Appendix A".
This incentive for underprovision of quality is caused by the assumed sequentiality of quality and price decisions, as shown by Ma and Burgess (1993).
Notice that the first-best solution is implemented for \(s<1\), which implies some degree of cost-sharing between consumers and the public funder.
With provider-specific prices, the first-best solution could also be implemented by including both private providers in the funding scheme, but the key point here is that inclusion of the second provider does not yield additional efficiency gains.
The proof of this proposition relies on a straightforward comparison of equilibrium expressions and is therefore omitted.
We thank an anonymous referee for helping us to pinpoint the exact mechanisms here.
Notice that social welfare is generally non-monotonic in the degree of funding coverage with a uniform regulated price. For example, if \(n=0\) and \(m=4\), the first-best outcome can be implemented for \(h=2\) but not for \(h=3\), since, in the latter case, the three covered providers cannot all compete directly with the uncovered provider. Thus, increasing the extent of funding coverage may worsen social welfare.
If \(n=1\), as in our model, the first-best solution can be implemented for any m if the pattern of funding coverage among the private providers is characterised by alternating funding status, starting with an uncovered provider next to the public firm, and where \(n+h=\left( n+m\right) /2\) if \(n+m\) is even and \(n+h=\left( n+m+1\right) /2\) if \(n+m\) is odd.
References
Bardey D, Canta C, Lozachmeur J-M (2012) The regulation of health care providers’ payments when horizontal and vertical differentiation matter. J Health Econ 31:691–704
Barros PP, Martinez-Giralt X (2002) Public and private provision of health care. J Econ Manag Strategy 11:109–133
Bennett J, La Manna M (2012) Mixed oligopoly, public firm behavior, and free private entry. Econ Lett 117:767–769
Boeskens L (2016) Regulating publicly funded private schools: a literature review on equity and effectiveness. OECD Education Working Papers, No. 147, OECD Publishing, Paris. Available at https://doi.org/10.1787/5jln6jcg80r4-en
Brunello G, Rocco L (2008) Educational standards in private and public schools. Econ J 118:1866–1887
Cellini R, Siciliani L, Straume OR (2018) A dynamic model of quality competition with endogenous prices. J Econ Dyn Control 94:190–206
Chang C-W, Wu D, Lin Y-S (2018) Price control and privatization in a mixed duopoly with a public social enterprise. J Econ 124:57–73
Chumacero RA, Gómez D, Paredes RD (2011) I would walk 500 miles (if it paid): vouchers and school choice in Chile. Econ Educ Rev 30:1103–1114
Cremer H, Marchand M, Thisse J-F (1989) The public firm as an instrument for regulating an oligopolistic market. Oxf Econ Pap 41:283–301
Cremer H, Marchand M, Thisse J-F (1991) Mixed oligopoly with differentiated products. Int J Ind Organ 9:43–53
De Fraja G, Delbono F (1989) Alternative strategies of a public enterprise in oligopoly. Oxf Econ Pap 41:302–311
Duggan M (2002) Hospital market structure and the behavior of not-for-profit hospitals. RAND J Econ 33:433–446
Ghandour Z (2021) Public-private competition in regulated markets. J Inst Theor Econ 177:299–336
Ghatak M, Mueller H (2011) Thanks for nothing? Not-for-profits and motivated agents. J Public Econ 95:94–105
Glaeser EL, Shleifer A (2001) Not-for-profits entrepreneurs. J Public Econ 81:99–115
Gravelle H, Sivey P (2010) Imperfect information in a quality-competitive hospital market. J Health Econ 29:524–535
Grilo I (1994) Mixed duopoly under vertical differentiation. Ann Econ Stat 33:91–112
Haraguchi J, Matsumura T (2016) Cournot-Bertrand comparison in a mixed oligopoly. J Econ 117:117–136
Haraguchi J, Matsumura T (2020) Optimal privatization policy with asymmetry among private firms. Bull Econ Res 72:213–224
Haraguchi J, Matsumura T (2020) Implicit protectionism via state enterprises and technology transfer from foreign enterprises. Rev Int Econ 28:723–743
Hehenkamp B, Kaarbøe OM (2020) Location choice and quality competition in mixed hospital markets. J Econ Behav Organ 177:641–660
Herr A (2011) Quality and welfare in a mixed duopoly with regulated prices: the case of a public and a private hospital. Ger Econ Rev 12:422–437
Ishibashi K, Kaneko T (2008) Partial privatization in mixed duopoly with price and quality competition. J Econ 95:213–231
Laine LT, Ma CA (2017) Quality and competition between public and private firms. J Econ Behav Organ 140:336–353
Lee J (2018) Understanding site selection of for-profit educational management organization charter schools. Educ Policy Anal Arch 26:77
Levaggi L, Levaggi R (2020) Is there scope for mixed markets in the provision of hospital care? Soc Sci Med 247:112810
Levaggi R, Montefiori M (2013) Patient selection in a mixed oligopoly market for health care: the role of the soft budget constraint. Int Rev Econ 60:49–70
Lutz S, Pezzino M (2014) Vertically differentiated mixed oligopoly with quality-dependent fixed costs. Manch Sch 82:596–619
Lyon TP (1999) Quality competition, insurance, and consumer choice in health care markets. J Econ Manag Strategy 8:545–580
Ma CA, Burgess JF (1993) Quality competition, welfare and regulation. J Econ 58:153–73
Matsumura T (1998) Partial privatization in mixed duopoly. J Public Econ 70:473–483
OECD (2020) PISA 2018 results (volume V): effective policies, successful schools. PISA, OECD Publishing, Paris. Available at https://doi.org/10.1787/ca768d40-en
Sanjo Y (2009) Quality choice in a health care market: a mixed duopoly approach. Eur J Health Econ 10:207–215
Siciliani L, Chalkley M, Gravelle H (2017) Policies towards hospital and GP competition in five European countries. Health Policy 121:103–110
Spence M (1975) Monopoly, quality and regulation. Bell J Econ 6:417–429
Stenbacka R, Tombak M (2018) Optimal reimbursement policy in health care: competition, ownership structure and quality provision. BE J Econ Anal Policy. https://doi.org/10.1515/bejeap-2017-0122
Willner J, Grönblom S (2021) Quality provision under conditions of oligopoly. J Econ 132:103–131
Acknowledgements
We thank three anonymous referees for valuable comments and suggestions. This paper is financed by National Funds of the FCT—Portuguese Foundation for Science and Technology within the project UID/ECO/03182/2019. Ziad Ghandour also acknowledges support from FCT through the PhD Studentship SFRH/BD/144210/2019
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
1.1 A. Equilibrium existence
1.1.1 No private provider is included in the public funding scheme
In the pricing subgame, the second order conditions are satisfied,
and equilibrium stability requires that the Jacobian is negative definite, which is easily verified:
In the quality subgame, there are two sets of conditions that do not trivially hold. First, the problem of each profit maximising provider is well-behaved if
and the problem of the welfare-maxmising provider is well-behaved if
Second, the Nash equilibrium is locally stable if the Jacobian is negative definite, which requires
and
All the above conditions are satisfied if \(k\ge {\underline{k}}\), where \({\underline{k}}\) is explicitly given by (12).
1.1.2 Inclusion of one private provider in the public funding scheme
In the quality subgame, there are two conditions that do not trivially hold. First, the problem of the welfare-maxmising public provider is well-behaved if
which requires \(k>15\beta ^{2}/16t\). Second, the Nash equilibrium is locally stable if the Jacobian of the system of first-order conditions is negative definite, which requires
and
(A8) holds if (A7) holds, while (A9) holds if \(kt\left( 16kt-23\beta ^{2}\right) +6\beta ^{4}>0\). Notice that
and
which implies that the condition in (A9) holds if k is above some threshold value higher than \(15\beta ^{2}/16t\), which in turn implies that (A7) and (A8) always hold if (A9) holds.
Furthermore, the regulator’s optimal pricing problem (for a given copayment rate) is well-behaved if
where
Assuming that \(\Theta >0\), the condition in (A12) holds if \(k>3\beta ^{2}/2t\) . Evaluating the numerator in (A9) at \(k=3\beta ^{2}/2t\) yields
Thus, the condition in (A9) always holds if (A12) holds. It remains to show that \(\Theta >0\). To do so, we derive
Notice that \(\partial ^{3}\Theta /\partial k^{3}>0\) if \(k>3\beta ^{2}/2t\). This implies that \(\partial ^{2}\Theta /\partial k^{2}\) is monotonically increasing in k. Evaluated at the lower bound \(k=3\beta ^{2}/2t\), we derive
Thus, \(\Theta\) is strictly convex for \(k>3\beta ^{2}/2t\). Furthermore,
and
Since \(\Theta\) is positive and increasing in k at \(k=3\beta ^{2}/2t\), and since \(\Theta\) is strictly convex for all \(k>3\beta ^{2}/2t\), it follows that \(\Theta\) is positive also for all \(k>3\beta ^{2}/2t\). Thus, the second-order condition (A12) is satisfied if
and this condition ensures that the critical conditions in the quality subgame, (A7)-(A9), are also satisfied.
1.2 B. Proof of proposition 1
(i) Plugging (36) and (37) into (30)–(33), it is easily confirmed that \(q_{1}^{**}=q_{2}^{**}=q_{3}^{**}=q^{fb}\) and that \(p_{3}^{**}=s^{fb}{\overline{p}}^{fb}\), which implies that \(D_{1}=D_{2}=D_{3}\). (ii) In the equilibrium outcome given by (20)–(22), the two private providers have equal quality and price levels, and in turn demand, while demand for the public provider is generally different. Aggregate transportation costs are minimised when each provider has the same demand. Setting \(D_{1}=D_{2}=D_{3}\) and solving for \(r_{1}\), we find that equal demand across the three providers is induced if \({\overline{p}}\) and s (recall that \(r_{1}=\) \(s{\overline{p}}\)) are set such that
This yields the following equilibrium qualities:
and
Since \(D_{1}=D_{2}=D_{3}=1/3\), this means that the average quality is given by
A comparison with the first-best quality yields
Thus, when the funding parameters are set such that aggregate mismatch costs are minimised, average quality provision is below the first-best level. Q.E.D.
Rights and permissions
About this article
Cite this article
Ghandour, Z., Straume, O.R. Optimal funding coverage in a mixed oligopoly with quality competition and price regulation. J Econ 136, 201–225 (2022). https://doi.org/10.1007/s00712-022-00778-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00712-022-00778-8